Larimar Therapeutics Swaps Common Shares for Series A Convertible Preferred Stock in Private Placement
I'm PortAI, I can summarize articles.
Larimar Therapeutics Inc. has exchanged 2,500,000 common shares for 250,000 Series A convertible preferred stock with Blue Owl Healthcare. The preferred stock is convertible at a 1-to-10 ratio, subject to ownership limits. The transaction was unregistered, relying on Section 3(a)(9) of the Securities Act. This AI-generated news is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments